Press Release
9 mayo 2024
Liège, Belgium – April 1, 2024 – CMD-COAT, a leading research and development company, and FRESCI, experts in health innovation, are proud to
In the forefront of healthcare technology, the Coati-X project stands as a testament to transformative innovation, funded by the European Innovation Council. This ambitious initiative, spearheaded by CMD-COAT SA in collaboration with FRESCI by SCIENCE&STRATEGY SL, aims to develop and to deliver a groundbreaking bioactive coating for medical devices, preventing infections and thrombosis.
Coati-X symbolizes European ingenuity and presents a hopeful vision for a future where medical devices are safer and more effective. Through collaboration, advanced technology, and a commitment to health advancement, the Coati-X project strives to revolutionize patient care and healthcare outcomes.
is to lead the transformation of medical device safety through innovative bioactive coatings, ensuring a safer and healthier future for patients worldwide.
is to develop and bring to market cutting-edge coating technologies that prevent infections and thrombosis in medical devices, enhancing patient outcomes and reducing healthcare costs.
We are committed to excellence in all we do, fostering innovation to solve critical healthcare challenges, and upholding the highest standards of integrity in our research and business practices.
COATI-X
We are pushing the boundaries of medical technology, delivering cutting-edge bioactive coatings that are antimicrobial, anti-thrombotic, hydrosoluble, and biocompatible. Our innovations enhance patient safety and improve healthcare outcomes.
Our core values guide everything we do. We strive for excellence with our advanced bioactive coatings, combining antimicrobial and anti-thrombotic properties. We foster innovation to tackle critical healthcare challenges, maintaining the highest integrity in all our practices.
We lead the way with our revolutionary bioactive coatings that prevent infections and thrombosis. Our water-based, non-toxic, and biocompatible solutions set new standards in patient care, ensuring a safer and more effective healthcare experience.
We believe in the power of collaboration. Working with top researchers and industry leaders, we bring our groundbreaking, hydrosoluble, and biocompatible technologies to life, making a lasting impact on global healthcare.
Liège, Belgium – April 1, 2024 – CMD-COAT, a leading research and development company, and FRESCI, experts in health innovation, are proud to
Kick-Off Meeting in Liège: FRESCI and CMD-COAT Teams Unite
On April 22nd, the FRESCI and CMD-COAT teams gathered at the Hospital of Liège
European Innovation Council
Privacy Policy © 2024 All rights Reserved. Design by FRESCI